Chikungunya vaccine, live (cvx 317)
Generic name: chikungunya vaccine, live (cvx 317) (none)
Brand name: Ixchiq (cvx 317)
Dosage form: intramuscular powder for injection (preservative-free)
Drug class: Viral vaccines
What is chikungunya vaccine?
This vaccine is used to prevent disease caused by the chikungunya virus in adults that are at high risk of coming into contact with the virus.
This vaccine will not treat an active infection that has already developed in the body, and will not protect against other diseases transmitted by mosquitoes.
Like any vaccine, the chikungunya vaccine may not provide protection from disease in every person.
Chikungunya vaccine side effects
Get emergency medical help if you have signs of an allergic reaction: hives, difficult breathing, swelling of your face, lips, tongue, or throat.
Chikungunya vaccine may cause low white blood cell counts. This usually occurs within the first week after receiving the vaccine. Tell your doctor if you have fever, mouth sores, skin sores, sore throat or cough. Your white blood cell counts may return to normal within 1 month.
You may have a severe reaction after receiving the vaccine. Call your doctor at once if you have fever, weakness, tiredness, headache, or severe muscle, back or joint pain. These symptoms may prevent you from daily activities, require a hospital stay, or last for weeks or months.
Common side effects of chikungunya vaccine, live may include:
-
pain, redness, swelling, or tenderness where the vaccine was injected;
-
headache, fever, weakness, tiredness; or
-
muscle or joint pain.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report vaccine side effects to the US Department of Health and Human Services at 1-800-822-7967.
Related/similar drugs
Ixchiq
Ixchiq is a chikungunya virus vaccine used to prevent chikungunya disease, it is a live, weakened ...
Abrysvo
Abrysvo vaccine protects against LRTD (lower respiratory tract disease) caused by the Respiratory ...
Benlysta
Benlysta infusion is used to treat active systemic lupus erythematosus (SLE) and active lupus ...
ACAM2000
ACAM2000 vaccine may be used to prevent smallpox and mpox disease in people of any age at high risk ...
Afluria
Afluria is a vaccine used to prevent infection caused by influenza virus. Learn about side effects ...
Afluria Preservative-Free Pediatric Quadrivalent
Afluria Preservative-Free Pediatric Quadrivalent is used for influenza prophylaxis
Afluria Preservative-Free Quadrivalent
Afluria Preservative-Free Quadrivalent is used for influenza prophylaxis
Afluria Quadrivalent
Afluria Quadrivalent is used for influenza prophylaxis
Arexvy
Arexvy is an RSV vaccine used to prevent severe Respiratory Syncytial Virus Vaccine (RSV) symptoms ...
Warnings
Tell your doctor if you use other medicines or have other medical conditions or allergies.
Before taking this medicine
You should not use chikungunya vaccine if you are allergic to it or its ingredients, or if you have a weak immune system (caused by disease or by using certain medicines).
Tell your doctor if you have or have ever had:
-
a bleeding or blood clotting disorder such as hemophilia;
-
an allergic reaction to any vaccine;
-
any other medical condition; or
-
any illness with a fever above 100.5 degrees F (38.0 °C).
Tell your doctor if you are pregnant or plan to become pregnant. Your doctor should determine whether you need this vaccine, especially if you have a high risk of infection with chikungunya. Having chikungunya during pregnancy may cause complications or medical problems in the baby.
If you are pregnant, your name may be listed on a pregnancy registry to track the effects of chikungunya vaccine on the baby.
Tell your baby's doctor if you received chikungunya vaccine during pregnancy, especially within the last 14 days before giving birth. It is not known if the chikungunya vaccine will pass the virus to the baby.
Ask a doctor if it is safe to breastfeed after receiving this vaccine.
How is this vaccine given?
This vaccine is given as a one-time injection (shot) into a muscle. You will receive this vaccine in a doctor's office, clinic setting, or pharmacy.
You may faint after receiving the chikungunya vaccine. You will be watched for a short time to make sure you are safe.
You should still use protection against mosquito bites even after you have received the vaccine. This includes wearing the appropriate clothing, insect repellents, and mosquito nets.
Chikungunya vaccine, live dosing information
Usual Adult Dose for Chikungunya Fever:
0.5 mL IM ONCE
Comments:
-This vaccine may not protect everyone against the chikungunya virus (CHIKV).
-Patients should take personal precautions to lower their risk of exposure to mosquito bites (e.g., use of adequate clothing, mosquito nets, repellants).
Use: For prevention of disease caused by CHIKV in patients at increased risk of exposure to CHIKV
What happens if I miss a dose?
Since chikungunya vaccine is given as a one time injection, you are not likely to be on a dosing schedule.
What happens if I overdose?
Since this vaccine is given by a healthcare professional, an overdose of chikungunya vaccine is unlikely to occur.
What should I avoid after receiving chikungunya vaccine?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
What other drugs will affect chikungunya vaccine?
Before receiving this vaccine, tell the doctor about all other vaccines you have recently received.
Also tell the doctor about all your other medicines, especially:
This list is not complete. Other drugs may interact with chikungunya vaccine, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.
Chikungunya vaccine, live (cvx 317) Biosimilars
Biosimilar and interchangeable products are biological products that are highly similar to and have no clinically meaningful differences from the reference product.
Reference products
These are biological products that have already been approved by the FDA, against which biosimilar products are compared. There is 1 for chikungunya vaccine, live (cvx 317).
IXCHIQ (Chikungunya Vaccine, Live) - Valneva Austria GmbH
Formulation type | Strength |
---|---|
Single-Dose Vial | 3.0 log10 TCID |
View IXCHIQ information in detail.
More about chikungunya vaccine, live (cvx 317)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: viral vaccines
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
- Your vaccination provider, pharmacist, or doctor can provide more information about this vaccine. Additional information is available from your local health department or the Centers for Disease Control and Prevention.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Copyright 1996-2025 Cerner Multum, Inc. Version: 1.01.